Drug Profile
Research programme: ciclosporin A analogues - Enanta
Alternative Names: Ciclosporin A analogues research programme - Enanta; Cyclosporin A analogues research programme - Enanta; EP 012637; EP 314; Research programme: cyclosporin A analogues - EnantaLatest Information Update: 04 Feb 2011
Price :
$50
*
At a glance
- Originator Enanta Pharmaceuticals
- Class Cyclic peptides
- Mechanism of Action T cell activation inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Asthma
Most Recent Events
- 19 May 2003 This programme is still in active development
- 10 Jul 2002 Enanta's cyclosporin A analogues are available for licensing in the USA (http://www.enanta.com)
- 10 Jul 2002 Preclinical trials in Asthma in USA (Inhalation)